Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors.
Magid AwadallaDoll Lauren Alexandra GoldenSyed S MahmoodRaza M AlviNathaniel D MercaldoMalek Z O HassanDahlia BanerjiAdam RokickiConnor MulliganSean P T MurphyMaeve Jones-O'ConnorJustine V CohenLucie M HeinzerlingMerna ArmaniousRyan J SullivanRongras DamrongwatanasukCarol L ChenDipti GuptaMichael C KirchbergerJavid J MoslehiSachin P ShahSarju GanatraPaaladinesh ThavendiranathanMuhammad A RizviGagan SahniAlexander R LyonCarlo G TocchettiValentina MercurioFranck ThunyStephane EderhyMichael MahmoudiDonald P LawrenceJohn D GroarkeAnju NohriaMichael G FradleyKerry L ReynoldsTomas G NeilanPublished in: Journal for immunotherapy of cancer (2019)
The rate of FV among ICI-related myocarditis cases was lower than controls on ICIs who did not develop myocarditis. In those who developed myocarditis related to an ICI, there was less myocardial injury and a lower risk of MACE among those who were administered the FV.
Keyphrases